StockInvest_us Posted - 4 hours ago

Signal alert: $BMRN - Overbought Trend Short (Overvalued) https://stockinvest.us/l/5gZWDFZsSz

Top_Dog_Pro_Trader Posted - 13 hours ago

$BMRN beat without Rox on Revenue and EPS. Only need to have a little positive news on Rox and this will rip higher! Vox is hitting it out of the park!

Estimize Posted - 14 hours ago

$BMRN beats the Estimize EPS Consensus by 7c and misses the Estimize Revenue Consensus by $5.05M. Reports FQ1 earnings of 46c EPS and $... http://www.estimize.com/bmrn/fq1-2024?utm_content=beat_or_miss&utm_medium=tweet&utm_source=stocktwits

CDMO Posted - 14 hours ago

$BMRN rocto revenue of 800.000$. That launch is really going great haha

DonCorleone77 Posted - 14 hours ago

$BMRN BioMarin raises FY24 adjusted EPS view to $2.75-$2.95 from $2.60-$280 Consensus for FY24 EPS is $1.65. Still sees FY24 revenue $2.7B-$2.8B, consensus $2.77B.

epsguid Posted - 14 hours ago

$BMRN reported earnings of $0.46, consensus was $0.37 via @eWhispers #epsbeat http://eps.sh/d/bmrn

DonCorleone77 Posted - 14 hours ago

$BMRN BioMarin reports Q1 non-GAAP EPS 71c, consensus 34c Reports Q1 revenue $649M, consensus $651.79M. "During the quarter, execution across our business led to double digit revenue growth, on a constant currency basis, and an 18% increase in non-GAAP diluted EPS. At the same time, we made rapid progress on advancing our strategic priorities for the year, including accelerating and maximizing the VOXZOGO opportunity, focusing R&D on the most productive assets, and increasing profitability," said CEO Alexander Hardy. "We were pleased with the outcome of our strategic R&D asset review, resulting in the acceleration and prioritization of the most potentially impactful medicines for patients... Quarterly results were driven by strong demand for VOXZOGO, the only approved treatment for children with achondroplasia, and solid contributions from our established enzyme products...Our registration-enabling plans with VOXZOGO in hypochondroplasia, and ongoing discussions with health authorities to align on development plans for idiopathic short stature and pathway conditions are on-track, with all three studies expected to begin enrollment this year."

Stock_Titan Posted - 14 hours ago

$BMRN BioMarin Reports Record Financial Results for the First Quarter 2024 https://www.stocktitan.net/news/BMRN/bio-marin-reports-record-financial-results-for-the-first-quarter-yc8l5b70j5ah.html

DonCorleone77 Posted - 14 hours ago

$BMRN BioMarin options imply 5.4% move in share price post-earnings Pre-earnings options volume in BioMarin is 7.0x normal with puts leading calls 19:6. Implied volatility suggests the market is anticipating a move near 5.4%, or $4.99, after results are released. Median move over the past eight quarters is 3.2%.

CDMO Posted - 15 hours ago

$BMRN up or down? My guess is pretty much flat

11thestate Posted - 18 hours ago

$BMRN agreed to settle $39M with investors over allegations of misleading or false statements over an FDA report. Even if the deadline has passed you can still file for a late claim:https://11thestate.com/cases/biomarin-shareholder-settlement

Estimize Posted - 19 hours ago

$BMRN reports after the close, Estimize Consensus +0.10 EPS and +1.66M Revs compared to WS http://www.estimize.com/bmrn/fq1-2024?utm_content=prerelease&utm_medium=tweet&utm_source=stocktwits

mauriz Posted - 22 hours ago

$CRDF $BMRN $AKBA I 'm following the same plan today, pretty Amazing!

bearcharts Posted - 1 day ago

Sold $BMRN at target 92-flat for $2 gain. (Acquired via opts assignment on Friday.) Will now write May strike-85 ⤰ 80 credit put spread.

Top_Dog_Pro_Trader Posted - 5 days ago

$BMRN $XBI $BBH $IBB $XLV Be interesting to see how Elliott is positioning the Company. Market has such low expectations, and is all worked up over Rox adoption. A bottom-up analysis on the pipeline and growth tells me Rox isn’t even in the shareprice. Vox is about 35% in the SP. Any positive news on Rox adoption or plans to increase adoption would be huge. Company says have patience with Rox, view the hurdles as short term.

mauriz Posted - 1 week ago

$BMRN $96.00 Is my short time target

mauriz Posted - 1 week ago

$BMRN hello ! new on biomarin . In for a swing trade in sight of QR

scienceleads Posted - 1 week ago

$BMRN poised for growth with 2 recently approved drugs.

muldoon92 Posted - 1 week ago

@Here4theartcle 💯 they’ve been talking about $BMRN as a prime takeover target for almost a decade now. Seems about right time to wrap it up with a bow tie and send it on its way

swingcobra Posted - 1 week ago

@sogenerous true. $BMRN seemed to have bounced off its recent lows.

muldoon92 Posted - 1 week ago

$BMRN something is clearly going on here… I’ve been largely ignoring my position for last few years bc of how boring it’s been. But this is… different. If I see followthrough Monday will add size. Something seems amidst this week

Tradelearner2022 Posted - 1 week ago

$BMRN - Strong uptrend heading towards earnings.

muldoon92 Posted - 1 week ago

$BMRN this has no reason at all to be positive today… something brewing? Activist team working on a buyout?

insiderbuyingselling Posted - 1 week ago

$BMRN new insider selling: 2286 shares. http://insiderbuyingselling.com/?t=BMRN

CDMO Posted - 1 week ago

$BMRN again very strong

Top_Dog_Pro_Trader Posted - 2 weeks ago

$BMRN type of accumulation on a down day that makes you think its getting aquired!

TheClockworkGroup Posted - 2 weeks ago

$BMRN #NASDAQ | The markets are unpredictable, but with hashtag#WaveE, one of our cutting-edge hashtag#AI-driven hashtag#algorithmic hashtag#breakout hashtag#daytrading strategies, you can make calculated trades like a pro! Scalped profits of $2,599.15 trading hashtag#BiomarinPharmaceutical, $BMRN shares today! Experience 100% automation! Experience 100% automation and compatibility with @MultiCharts, @NinjaTrader & @TradeStation...

trendtrader6 Posted - 2 weeks ago

$BMRN daily chart breaking out of a short term set up. looks like it should test the medium term setup at 94ish soon.

trendtrader6 Posted - 2 weeks ago

$BMRN weekly chart. great strength today in a choppy marker. 95/100/110

BasedInvestor Posted - 2 weeks ago

$BMRN seeing a lot of unusual calls on the Bullflow unusual options platform, anyone know of upcoming catalysts for this stock?